Medley Therapeutics Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$30.1M
- Investors
-
3
Medley Therapeutics General Information
Description
Operator of a biotechnology company intended to help in the regeneration of genes. The company develops genetic medicines that leverage the latest gene therapy technologies to reverse and cure severe diseases, providing patients with a means to live a healthier life.
Contact Information
Website
www.medleytx.comCorporate Office
- 26051 Merit Circle
- Suite 102
- Laguna Hills, CA 92653
- United States
Corporate Office
- 26051 Merit Circle
- Suite 102
- Laguna Hills, CA 92653
- United States
Medley Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series B) | 31-Jan-2022 | $30.1M | Completed | Generating Revenue | ||
| 1. Later Stage VC (Series A) | 01-Mar-2021 | Completed | Generating Revenue |
Medley Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Medley Therapeutics Patents
Medley Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024006898-A2 | Gene therapy of hippo signaling improves heart function in a clinically relevant model | Inactive | 29-Jun-2022 | ||
| WO-2024006898-A3 | Gene therapy of hippo signaling improves heart function in a clinically relevant model | Inactive | 29-Jun-2022 | ||
| JP-2025524525-A | Hippo signaling gene therapy improves cardiac function in clinically relevant models | Pending | 29-Jun-2022 | C12N15/113 |
Medley Therapeutics Signals
Medley Therapeutics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BCM Ventures | Venture Capital | Minority | ||
| Fjord Ventures | Venture Capital | Minority | ||
| ArrowMark Partners | Asset Manager | Minority |
Medley Therapeutics FAQs
-
When was Medley Therapeutics founded?
Medley Therapeutics was founded in 2016.
-
Where is Medley Therapeutics headquartered?
Medley Therapeutics is headquartered in Laguna Hills, CA.
-
What is the size of Medley Therapeutics?
Medley Therapeutics has 6 total employees.
-
What industry is Medley Therapeutics in?
Medley Therapeutics’s primary industry is Biotechnology.
-
Is Medley Therapeutics a private or public company?
Medley Therapeutics is a Private company.
-
What is the current valuation of Medley Therapeutics?
The current valuation of Medley Therapeutics is .
-
What is Medley Therapeutics’s current revenue?
The current revenue for Medley Therapeutics is .
-
How much funding has Medley Therapeutics raised over time?
Medley Therapeutics has raised $31.1M.
-
Who are Medley Therapeutics’s investors?
BCM Ventures, Fjord Ventures, and ArrowMark Partners have invested in Medley Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process